TerrAscend Corp (TED) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.081x

Based on the latest financial reports, TerrAscend Corp (TED) has a cash flow conversion efficiency ratio of 0.081x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€8.01 Million ≈ $9.37 Million USD) by net assets (€99.02 Million ≈ $115.77 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is TerrAscend Corp worth for the company's overall valuation and market capitalisation.

TerrAscend Corp - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how TerrAscend Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data.

TerrAscend Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of TerrAscend Corp ranked by their cash flow conversion efficiency. Explore TerrAscend Corp earnings quality ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
RAINBOW RARE EARTHS LTD F:RR1	N/A
Dafeng TV Ltd TW:6184	0.010x
Eureka Group Holdings Ltd AU:EGH	0.029x
Lynch Group Holdings Ltd AU:LGL	0.146x
Asflow Co. Ltd. KQ:159010	-0.025x
Harvatek Corp TW:6168	-0.006x
CB Financial Services Inc NASDAQ:CBFV	0.046x
Ames National Corporation NASDAQ:ATLO	0.013x

Annual Cash Flow Conversion Efficiency for TerrAscend Corp (2016–2025)

The table below shows the annual cash flow conversion efficiency of TerrAscend Corp from 2016 to 2025. View TerrAscend Corp (TED) share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€99.02 Million ≈ $115.77 Million	€21.53 Million ≈ $25.17 Million	0.217x	+1.29%
2024-12-31	€176.82 Million ≈ $206.72 Million	€37.95 Million ≈ $44.37 Million	0.215x	+88.09%
2023-12-31	€240.74 Million ≈ $281.45 Million	€27.47 Million ≈ $32.12 Million	0.114x	+240.29%
2022-12-31	€321.17 Million ≈ $375.48 Million	€-26.12 Million ≈ $-30.54 Million	-0.081x	+41.47%
2021-12-31	€228.95 Million ≈ $267.67 Million	€-31.82 Million ≈ $-37.20 Million	-0.139x	+95.82%
2020-12-31	€11.12 Million ≈ $13.00 Million	€-36.97 Million ≈ $-43.22 Million	-3.326x	-528.79%
2019-12-31	€75.33 Million ≈ $88.07 Million	€-39.84 Million ≈ $-46.58 Million	-0.529x	-51.78%
2018-12-31	€57.90 Million ≈ $67.69 Million	€-20.18 Million ≈ $-23.59 Million	-0.348x	-465.69%
2017-12-31	€67.37 Million ≈ $78.76 Million	€-4.15 Million ≈ $-4.85 Million	-0.062x	+69.67%
2016-12-31	€2.08 Million ≈ $2.43 Million	€-422.64K ≈ $-494.11K	-0.203x	--

About TerrAscend Corp

F:TED Germany Drug Manufacturers - Specialty & Generic

Market Cap

$189.64 Million

€162.21 Million EUR

Market Cap Rank

#16825 Global

#1587 in Germany

Share Price

€0.52

Change (1 day)

-4.73%

52-Week Range

€0.30 - €1.09

All Time High

€13.10